Results showed that there was a significant association be­tween CYP2A6*4 polymorphism and lung cancer risk (additive model, pooled OR  = 0.826, 95% CI  = 0.725–0.941, P-value  = 0.004). The gene discussed is CYP2A6; the disease is lung cancer.